2010 Nobel-Pauling Biotech Symposium speakers WEST meets new EAST & seeks global synergy-Speakers from USA, Europe & Asia 2010 Nobel Pauling Symposium Speakers Mr. Stéphane Hogan MSc, MBA. Head of Coordination Unit, Directorate Health, DG Research, European Commission. Dr. Roger Bossé Ph.D PerkinElmer, Canada Troy A. Groetken Shareholder, McAndrews Held & Malloy LTD Dr. Rashmi H. Barbhaiya CEO, Managing Director and co-founder Advinus Therapeutics, India Dr. Allan Riting Liu MD, PhD, MBA. Vice President, Wanbang Biopharmaceutical Group, Director of Business Development, Fosun Pharma Group Dr. Ying Luo Chairman and CEO Shanghai Genomics Inc, GNI Ltd, China Birger Sørensen CEO, Bionor Immuno AS, Norway Dr. Andreas Kage CSO, AptaRes AG, Germany Prof Douglas J. Cork IIT & MHRP/HJF, Walter Reed Army Institute of Research Dr. Chei-Hsiang Chen Director, Biotechnology and Pharmaceutical Industries Program Office (BPIPO) Dr. Rajendra Mehta Assistant VP and Head of the Cancer Biology, Head of Drug Discovery Divisions at IIT Research Institute Prof Dr. Jaap Goudsmit CSO, Crucell, The Netherlands Dr. Grace Wong CEO, ActoKine Therapeutics, Boston, USA About Dr. Linus Pauling, (1901-1994) Dr. Linus Pauling's Life Chronology Click here to register & pre-registration is required, see agenda 2003 to 2009 Nobel Pauling Symposium Speakers Dr. Jeremy Levin D Phil, MB B. Chir, Global Head of Business Development and Strategic Alliances for Novartis Dr. Andrew Denker MD, PhD. Senior Director, Clinical Pharmacology, Merck Research Laboratories Title: Phase I Studies: a Worldwide Approach Jim Sherblom Managing General Partner, Seaflower Ventures Dr. Arthur J. Coury Ph.D, Vice President, Biomaterials Research, Genzyme Mr Carlos Genardini Hong Kong Science and Technology Parks Seminar Title: "Reality Check--Can Entrepreneurs Succeed in China's Life Science Business Dr. Makarand Jawadekar Director, Pfizer Seminar Title: "The East is new West" Dr. Zhenping Zhu MD, PhD Vice President, ImClone Dr. Manfred Auer PhD., Executive Director, Novartis Institutes for BioMedical Research GmbH & Co KG Ms. Chen Xiaohui General Director, Economy & Trade Development Bureau, Songshan Lake Science and Technology Industry Park, Dongguan, China Mr. Li Hang Deputy Director General, Techonology & Education Development Bureau, Songshan Lake Science and Technology Industry Park, Dongguan, China Dr Chris Song PhD, MBA, Applied Biosystems, China Dr Dilip Limaye PhD, CEO, Indipharm, India Dr. James Zhu PhD Partner, Perkins Coie Dr. Claude G Biava MD, PhD, CMO, ActoKine Therapeutics Dr. Benjamin Lee PhD, CEO, Comprehensive Drug Enterprises, Hong Kong Prof. Moses Chow PhD, Professor, Chinese University of Hong Kong Dr. Robert Zivin Corporate Director, Johnson & Johnson Dr. Steven R. Gullans CEO & co-founder, RxGen Dr. Amanda Caples Director-Biotechnology, State Government of Victoria, Australia Dr. David Irving PhD, CEO, Diabetes Vaccine Development Centre, Australia Kerry Doyle Executive Director, NSW Office for Science and Medical Research Mr. Ali Hussein CEO, Science24Seven, LLC, Cambridge, USA Dr. Lorenz Ng M.D, Managing Partner, Global Ng Associates, LLC, Former VP, Eli Lilly Asia Dr. Stephen Lam PhD, MBA, Head, Biotechnology, HKSTP Dr. Richard Gill Ph.D. CEO, ProNAi Therapeutics, USA Dr. Blessed Okole PhD, CEO, Lifelab, South Africa Glenn Rice, PhD, CEO, XinBridge, China Claude Ranoux M.D., M.S., Founder, President and CEO, BioXcell, France Mr. Jean-François Mouney Chairman and CEO, Founder, Genfit Corp, France Dr. Qiang Yu PhD, CEO, Ambrosia Pharmaceutical Co, Shanghai, China Mr. Lance Han M. Eng, MBA: CEO, Cyagen, Guangzhou, China Dr. Yaozhou Shi PhD, VP, Shanghai Biochip, China Dr. Maggie Zhang Clinical Trial Design and Management, Johnson & Johnson, PA, USA Dr. Christoph Hüls PhD - CEO, Protagen AG, Germany Dr. Stefan Müllner PhD - CSO, Protagen AG, Germany Dr. Chuck Caprariello Ranbaxy Labs. Ltd., India Mr. Sridhar Mosur CEO & President, Jubilant Biosys Ltd., New Delhi and Bangalore, India Dr James N Little senior executive, Former Waters, Zymark and Cetek Kevin Zhou MBA, CEO, SSTK Biotech, Shenzhen, China Mr. Karl Handelsman Managing Director, CMEA Ventures Dr. Kevin Li Ph.D Partner, HBM BioMed China Dr. Bing Wong CEO, Advantek Biologics, Hong Kong Dr. Albert C. H. Yu CEO, HKDNA Chips, Bejing, China Dr. Stephen H. Ip Ph.D.Senior Vice President, Global Business Development, TaiGen, Taiwan Dr. Zhijian Lu PhD Associate Director, Wyeth Dr. Wei-Wei Zhang MD, PhD, founder, President and CEO, GenWay Biotech, USA Gordon Vehar PhD VP of Research, Raven Biotechnologies, SSF, CA, USA Choong-Chin Liew PhD, Chief Scientist, GeneNews, Toronto, Canada Dr. Frank Liu, PhD, AstraZeneca Dr. Subhash Dhawan, PhD, Senior Investigator, Center for Biologics, FDA Dr. Reinhard Ebner PhD, Director of Research, Avalon Pharmaceuticals Dr. Kenneth C. Carter PhD, President & CEO of Avalon Pharmaceuticals Dr. Yupeng David He PhD Abbott Laboratories Dr. Jeff Moore PhD, MBA, Kauffman Fellow, RCT BioVentures Dr. Paul Smaglik Naturejob Editor Dr. Andy Peng Xiang COO, Cyagen Dr. Timothy Wells PhD, Former Head of Research, MerckSerono Dr. Zach Jonasson Ph.D. - Senior Principal, Seaflower Ventures Dr. Steve Arkinstall PhD, Head of Discovery, EMDSerono Dr Frank Lee CEO, Dragonfly, Shanghai, China Huo Li, PhD Biogen-Idec Mr. Iskandar Mizal Mahmood Chief Executive Officer, BiotechCorp Dr. Thomas Li Head of Asia Pacific Technology Management, Roche, Singapore Corie Lok Senior Editor, Nature Network Patricia Turney Director, R&D Strategic Operations, Amgen Mr. Kevin Cronin CEO, Techlawglobal, Beijing, China Edward Brennan COO, Indipharm, India Matthew Levy MBA, Director, Applied Biosystems, Beijing, China Dr. Zhi-Qiang Ning MD., PhD, Co-founder, Chipscreen, Shenzhen, China Dr. Andrew Marshall PhD, Nature Biotechnology Dr Mark Farmery PhD, Team leader, Astrazeneca, Sderlje, Sweden Dr. Grace Wong PhD, Chief Scientific Officer, ActoKine Therapeutics 11th Nobel Pauling Symposium Speakers Mr Carlos Genardini Hong Kong Science and Technology Parks Dr. Napoleone Ferrara Genentech Fellow, Molecular Oncology, Genentech Dr. Ellen Filvaroff Scientist Molecular Oncology, Genentech Mr. Thomas H. Bliss, Jr. International Licensing, Amgen Dr. Mao Mao Associate Director, Merck Professor Johan PE Karlberg MD, PhD, BSc, Director, Clinical Trials Centre, University of Hong Kong Dr. Thomas Li Head of Asia Pacific Technology Management, Roche Singapore Dr. Brian Wong MD, PhD, Director, Roche Dr. Jingsong Wang MD, PhD, Associate Director, Wyeth PA Eric Morfin PMP, PMO Director, Novartis Vaccines and Diagnostics Dr. Jonathan Liu DVM, PhD, Director, MedImmune Rick Bott PhD, Staff Scientist, Genencor (Danisco) Dr. Charles Hsu PhD, MBA, Venture Partner Mr. Karl Handelsman Managing Director, CMEA Ventures Dr. Grace Wong PhD, Chief Scientific Officer, ActoKine Therapeutics The goal is to build a bridge between academia and industry between USA, Europe, Australia and Asia 8th, 9th & 10th Nobel Pauling Symposium Speakers Click on a speaker's name to go to another page with their biography. Carlos Genardini Hong Kong Science Park John Lo, OBE, JP, PhD Hong Kong Science Park Bill Cafruny, PhD University of South Dakota Jerry Yang, PhD University of Connecticut Ming Chiu Fung, PhD CUHK Ricky K.N. Leung, PhD CUHK Mak Nai Ki, PhD, Hong Kong Baptist Univesity Benny Zee, PhD CUHK Soumyaroop Bhattacharya Harvard Paul Smaglik, PhD NatureJob Editor Dyke Hendrickson, Mass High Tech Myrna E. Watanabe, PhD Science writer Kenneth J. Dillon, PhD Spectrum Bioscience Gunther Winkler, PhD VP, Biogen-Idec Huo Li, PhD Biogen-Idec, Dennis France, VP, Arqule Steve Gullans, PhD Rx-gen Kevin Li, PhD Fountain Pharmaceuticals James Wang, PhD Hypromatrix Michael Kinch, PhD MedImmune Xinhua Li, PhD Genzyme Canwen Jiang, PhD Genzyme Seng H. Cheng, Ph.D Genzyme Huawei Qiu, PhD Genzyme Reinhard Ebner, PhD Avalon Pharmaceuticals Marsha Paul, PhD Caliper Life Science William R. Shek, PhD, Charles River Lab. Adam Bell, PhD CoGenesys (HGS)  David Merberg, PhD Cell Signaling Technology Elizabeth Abraham, PhD ViaCell Lex Van der Ploeg, PhD Merck Robert Gould, PhD Merck Laura Chavez-Noriega, PhD Merck Reid Leonard, PhD Senior Director, Merck James Leung, PhD Biomeasure Norrie Russell, PhD Invitrogen Scott Wadsworth, PhD Johnson & Johnson Bob Zivin, PhD Johnson & Johnson Sergey Ilyin, PhD Johnson & Johnson Philip J. Vickers, PhD Pfizer Ralph H. Lambalot, PhD Pfizer Ajith Kamath, PhD Associate Director, Pfizer Rajiv Shukla, PhD Pfizer Yuan-Hua Ding, PhD  Pfizer Leyu Wang, PhD Pfizer Brian Wong, PhD Roche Yong Jia, PhD Abbott David He, PhD Abbott Joanne Kamens, PhD Abbott Jun Han, PhD Novartis Chandrika Kumar, PhD Novartis Dejan Bojanic, PhD Novartis Christopher P. Miller, PhD Wyeth ZhiJian Lu, PhD  Wyeth Gangfeng Xu, PhD, MBA  Wyeth Christopher Sampson, Manager, AstraZeneca Jason A. Slusher, Site Head, Sanofi-Aventi Ben Askew, PhD Serono Timothy Wells, PhD Serono Steve Arkinstall, PhD Serono Keith Robison, PhD Millennium Frank Hsieh, PhD Millennium Grace Wong, PhD ActoKine Therapeutics Linus Pauling Keynote Speakers Alexander Rich, MD MIT Louis Tartaglia, PhD Millenium Timothy Wells, PhD Serono Steve Arkinstall, PhD Serono Dalia Cohen, PhD Novartis Robert Allen Lewis, MD Aventis Steve Wiley, PhD Amgen Napoleone Ferrara, PhD Genentech Jeffrey Browning, PhD Biogen Wolfgang Ketterle, PhD MIT Eugene L. Brown, PhD Wyeth Dr. Leroy Hood, MD, PhD Inst. for Systems Biology Lex Van der Ploeg, PhD Merck Pharmaceutical Companies John Zawad, PhD Aventis Scott Wadsworth, PhD Johnson & Johnson Francis Xavier Farrell, PhD Johnson & Johnson Kuldeep Neote, PhD Pfizer Shi-Chung Ng, PhD Abbott Kevin Xie, PhD Bayer Sridaran Natesan, PhD Aventis Lee Babiss, PhD Hoffmann-La Roche Alexander Sasha Kamb, PhD Novartis Institute Joanne Kamens, PhD Abbott Suxing Liu, PhD Schering-Plough Jeanette Wood, PhD Novartis Jacky Vonderscher, PhD Novartis Thomas Seng-Lai Tan, PhD Eli Lilly & Company Suresh B. Singh, PhD Merck Anton Beletskii, PhD Abbott Michael A. Mallamaci, PhD AstraZeneca Jianling Wang, PhD Novartis Institute Hing Leung Sham, PhD Abbott Privately Held Biotech Companies Reinhard Ebner, PhD Avalon Pharmaceuticals Brent L. Kreider, PhD Akceli Kenneth Carter, PhD Avalon Pharmaceuticals James Strickler, PhD Suntory Pharmaceuticals Yat Sun Or, PhD Enanta Pharmaceuticals Pat Gray, PhD MacroGenics Andrew Mazar, PhD Attenuon LLC Jeffrey Peterson Target Discovery Lynn Doucette-Stamm, PhD Agencourt Bioscience Martin A. Wasserman, PhD AtheroGenics Karoly Nikolich, PhD AGY Therapeutics Steven R Gullans, PhD US Genomics Jennifer Shore StemCell Technologies Frank Y. Xie, PhD Intradigm Corporation David Merberg, PhD Cell Signaling Technology John Maraganore, PhD Alnylam Jeffrey Hillman, DMD, PhD IviGene Randall K. Wetzel, PhD Cell Signaling Technology Jeff Brockman, PhD Psychiatric Genomics Gordon Vehar, PhD Raven Biotechnologies Arnon Rosenthal, PhD Rinat Neuroscience Frank Striggow, PhD KeyNeurotek Mark Tepper, PhD Araios Sunkwei Huang, PhD ActivBiotics Amy L. Rubinstein, PhD Zygogen Kathy Hehir TranXenoGen Erdogan Memili, PhD GTC Biotherapeutics Daniel Hu, PhD Bonature James Wang, PhD Hypromatrix Cytokine Companies Linda Burkly, PhD Biogen Meena Subramanyam, PhD Biogen Martin Scott, PhD Biogen Matthew Cooper, PhD Biogen Richard L. Cate, PhD Biogen Dinah W. Sah, PhD Biogen Akshay K. Vaishnaw, MD, MRCP, PhD Biogen Marianne T. Sweetser, MD, PhD Biogen Diane Pennica, PhD Genentech Hans-Peter Gerber, PhD Genentech Thomas D. Wu, MD, PhD Genentech Andrew Chan, MD, PhD Genentech Grace Wong, PhD ActoKine Therapeutics Publicly Held Biotech Companies David Leung, PhD Cell Therapeutics Tomi Sawyer, PhD ARIAD Pharmaceuticals Kevin Foley, PhD Millennium David White, PhD Millennium Keith Robison, PhD Millennium Zhenping Zhu, MD, PhD ImClone Systems Irina Agoulnik, PhD Millennium Tarif A. Awad, PhD Affymetrix Brian Zambrowicz, PhD Lexicon Genetics Timothy Hoey, PhD Tularik Roy Pollock, PhD ARIAD Pharmaceuticals John Randle, PhD Vertex Pharmaceuticals Mark Namchuk, PhD Vertex Pharmaceuticals Juan A. Ruiz, PhD, MBA Transkaryotic Therapies Academic and Other Institutions Sonia Sparks Wallman, PhD NH Biotech Council Sonia Guterman, PhD Mintz Levin Tolleiv Trimborn, PhD Life Sciences Partners VC Sunny Tam, PhD Charles River Lab Andy Bhattacharjee, PhD Agilent James Lyons-Weiler, PhD University of Pittsburgh Shuguang Zhang, PhD MIT Kim Seth, PhD Harvard Iain Campbell, PhD Scripps David Vaux, MD, PhD Walter & Eliza Hall Institute Li-An Yeh, PhD Harvard Andrew Marshall, PhD Nature Biotechnology Arthur Pardee, PhD Harvard King Li, MD NIH Clinical Center Howard Martin Fillit, MD The Aging Institute Irene Bosch, PhD UMASS Medical School Lee Marshall Ellis, MD Anderson Cancer Center Thomas D Gilmore, PhD Boston University Seth Cohen, PhD LRIG Mark Kon, PhD Boston University John J. Rossi, PhD City of Hope Pavel Hradecky, MD Harvard University Jeremy Zucker Dana-Farber Cancer Institute Advice from experts Richard Gregory, PhD Genzyme Alex Harris, PhD Chiron Michael Kinch, PhD MedImmune David G. Lowe, PhD Skyline Ventures Bruce Stillman, PhD Cold Spring Harbor David Baltimore, PhD Caltech Charles M. Vest, PhD former President of MIT Michael Brown, PhD Southwestern Medical School David de Kretser, MD Monash Institute Jordan S. Pober, MD, PhD Yale University Sir Gus Nossal, former Head of WEHI Institute If you would like to be involved with the 2007 Pauling Symposium please email Alex Pauling at alex at pauling.us. Home | Mission | Registration | Sponsors | Job Strategies | News, Events, Contact Biotech Booth | Event Photos | Nobel Day | Dr. Linus Pauling | Who's Who Pauling Biotech Symposium | Symposium Agenda | Symposium Speakers | Symposium Testimonials Founder & Board of Directors | Scientific Advisory Committee | Scholarship Application copyright 2010